Evidence map›Paper›PMID 42845893›Full record

ArticleFrontiers in medicine2026

Could persistent extravascular fibrin deposition link microvascular and interstitial pathology in long COVID?

Keiko Kubo

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Keiko KuboHSG Interstitial Research Lab (HIRL), Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long COVID is associated with persistent endothelial dysfunction, microvascular impairment, coagulation abnormalities, impaired fibrinolysis, and tissue hypoxia. Although these intravascular abnormalities are increasingly documented, less attention has been paid to whether vascular injury may also generate persistent pathology in the extravascular interstitial compartment. We propose chronic intra- and extravascular coagulation (CIEC) as a continuous pathological mechanism in which COVID-associated immunothrombosis and endothelial injury may be followed by vascular leakage, local extravascular fibrin formation, and incomplete resolution of a fibrin-containing provisional matrix. At a different level, the dual-axis microvascular-interstitial model (DMIM) describes how abnormalities on both sides of the vascular wall may interact functionally: impaired microvascular tissue supply (Axis 1) together with abnormal interstitial mechanics and diffusion (Axis 2) may contribute to tissue dysfunction and symptoms. This framework links established microvascular pathology with a proposed extravascular component and provides testable predictions for histological, biochemical, molecular-imaging, microcirculatory, and biomechanical studies in long COVID.

Indexed as

endothelial dysfunctionextravascular coagulationfibrin depositionimmunothrombosisimpaired fibrinolysisinterstitial pathologylong COVIDpost-acute sequelae of SARS-CoV-2 infection (PASC)

Identifiers

PMID42845893
PMCPMC13642121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.